Researchers found that including post-discharge MRSA rates tripled the median hospital-onset MRSA incidence rate, consequently altering hospital rankings significantly, according to research published in Infection Control and Hospital Epidemiology.
The Latest
The Institute of Medicine has published a report outlining 10 attributes of a health literate organization, designed to help healthcare providers, including hospitals, health systems, physician groups and payors, understand how to foster health literacy among patients.
Researchers found significant gaps in quality care delivered to patients with diabetes, according to research published in Health Affairs.
Effectively managing a surgery center's supplies can cut costs and raise profits. But what about must-have supplies that are so expensive they single-handedly threaten the profitability of a case? Surgery center administrators and physicians share some high-cost supplies and how…
A new book aims to help ophthalmologists develop innovative computer systems to provide critical support and better care options for patients by applying computational modeling methods, according to a Lousiana Tech University news release.
The FDA granted 510(k) clearance to Ivera Medical's Curos disinfecting port protector, designed to reduce hospital-acquired catheter related bloodstream infections, according to a company news release.
Federal prosecutors dropped all charges against former Stryker sales manager David Ard, who was charged with illegally promoting the off-label use of bone growth products and lying to the FDA, according to a MassDevice report.
Researchers found the benefits of muscle relaxants and neuromodulators for treating rheumatoid arthritis pain don't outweigh the side effects, according to a news release.
Bayer HealthCare will seek FDA approval for its new colorectal cancer drug, regorafenib, and if approved, the drug would be the first new drug to treat colorectal cancer in more than five years, according to a Los Angeles Times report.
A new study found using lectins, a naturally occurring protein, labeled with fluorescence highlighted areas of high-grade dysplasia and cancer in the esophagus, according to findings published in Nature Medicine.